Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Feb 4, 2021 (6 years ago)

Meclizine HCl Tablets

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Dissolution Specifications

Cause type: Dissolution failure

The tablet or capsule did not dissolve within specification. Dissolution controls how much drug the body absorbs; a failure can change the effective dose. All dissolution failure recalls.

What was recalled

Meclizine HCl Tablets, USP, 25 mg, 100 Tablets bottles, Rx Only, Mfd. for: Wilshire Pharmaceuticals, Inc., Atlanta, GA 30328, Product of India, NDC 52536-133-01

Affected NDC 52536-0133-01

Compare with the code on your package — it is the most precise check available.

Drug: Meclizine

Recalling firm
Wilshire Pharmaceuticals Inc
NDC code
52536-133-01
Origin
GA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0259-2021 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Meclizine recalls

See all
Class I · High risk

Meclizine Hydrochloride Tablets USP

Labeling: Label mix-up: Incorrect label placed on product. Shipper cases labeled Meclizine Hydrochloride Tablets contain bottles incorrectly labeled as PredniSONE Tablets. The tablets in the bottles are Meclizine Hydrochloride

Terminated Labeling / mix-up Jubilant Cadista Pharmaceuticals, Inc. NDC 59746-122-06 D-0767-2022

Other recalls by Wilshire Pharmaceuticals Inc

All 2021 recalls